Cure Ventures Management, LP
curevc.com Direct investor
Cure Ventures is a life sciences venture capital firm founded in 2021 that focuses on company formation around groundbreaking curative technologies. It invests at the seed stage and follows through hands-on, leveraging genetic validation to increase success probability.
Cure Ventures Management, LP is a venture capital firm headquartered in Boston, United States, founded in 2021. It invests directly in companies, from seed to Series A, in life sciences, biotech, drug discovery and therapeutics. $350 million under management and 12 portfolio companies, as it reports.
“Cure is focused on de novo company formation. We closely collaborate with visionary scientists to identify breakthrough ideas that have the potential to become exceptional companies.”
— Cure Ventures Management, LP, own website
- Layer
- Direct investor
- Type
- Venture capital
- Headquarters
- Boston, United States
- Sectors
- life sciences, biotech, drug discovery, therapeutics
- Founded
- 2021
- Assets under management
- $350 million
- Portfolio
- 12 companies
Team, as Cure Ventures Management, LP publishes it
- William Amsbaugh CTO and Partner
- Milenko Cicmil Venture Partner
- David Fallace Managing Partner
- Jeno Gyuris Partner
- May Han Partner
- Jeffrey M. Jonas Partner
Names and roles exactly as listed on curevc.com. Nothing else about these people is recorded.
Co-invests most often with
Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 5 co-investors found.
- The Column Group 2 shared companies: tortugasneuro.com, kenaitx.com
- ARCH Venture Partners 1 shared company: recurohealth.com
- Deepwork Capital, LLC 1 shared company: recurohealth.com
- Mission Bay Capital 1 shared company: alessatherapeutics.com
- Mission BioCapital 1 shared company: alessatherapeutics.com
Where this comes from
Every fact above was read from a page Cure Ventures Management, LP publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://www.curevc.com/name, is_investor, hq_country, hq_city, sectors, aum, status, confidence
- https://www.curevc.com/approach/layer, stage_min, thesis_quote
- https://www.curevc.com/about-us/type, description, founded
- https://www.curevc.com/companies/stage_max, portfolio_count
- https://www.curevc.com/people/people
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 3235 · added 2026-09-03 · link last verified 2026-09-06 · confidence high
Similar investors
- Atlas VentureVenture capital · Seed – Series A · Cambridge, United States
- Avalon BioVentures Management, LLCVenture capital · Seed – Series A · San Diego, United States
- Iaso VenturesVenture capital · Cambridge, United States
- Mission BioCapitalVenture capital · Seed – Series A · Cambridge, United States
- RA Capital ManagementVenture capital · Pre-seed – Growth · Boston, United States
- Samsara BioCapital, LLCVenture capital · Series A – Series C+ · Palo Alto, United States